Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Eperzan/Tanzeum

PharmaCompass

01

Brand Name : Eperzan/Tanzeum

Albiglutide

arrow
Antibody Engineering
Not Confirmed

Brand Name : Eperzan/Tanzeum

arrow
Antibody Engineering
Not Confirmed

Albiglutide

Main Therapeutic Indication : Diabetes

Currency : USD

2016 Revenue in Millions : 150

2015 Revenue in Millions : 50

Growth (%) : 200

blank

02

Brand Name : Eperzan/Tanzeum

Albiglutide

arrow
Antibody Engineering
Not Confirmed

Brand Name : Eperzan/Tanzeum

arrow
Antibody Engineering
Not Confirmed

Albiglutide

Main Therapeutic Indication : Diabetes

Currency : USD

2017 Revenue in Millions : 123

2016 Revenue in Millions : 171

Growth (%) : -28

blank

03

Brand Name : Eperzan/Tanzeum

Albiglutide

arrow
Antibody Engineering
Not Confirmed

Brand Name : Eperzan/Tanzeum

arrow
Antibody Engineering
Not Confirmed

Albiglutide

Main Therapeutic Indication : Diabetes

Currency : USD

2018 Revenue in Millions : 41

2017 Revenue in Millions : 116

Growth (%) : -64%

blank